Projects per year
Fingerprint
Dive into the research topics where William Figg is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Clinical Pharmacology and Drug-Drug Interactions in HIV-Associated Malignancy
1/10/20 → 30/09/24
Project: Research
-
-
Pharmacokinetic and Pharmacodynamic Modeling of Anticancer Agents
Figg, W. & Figg, W. D.
1/10/08 → 30/09/18
Project: Research
-
A phase 2 study of single agent ibrutinib for first-line treatment of chronic graft-versus-host disease: A new paradigm and lessons learned
El Jurdi, N., Holtzman, N. G., Hishmeh, R., Mina, A., Schulz, E., Stokes, A., Li, G., Schmidt, K. T., Figg, W. D., Micheletti, N., Mays, J. W., Cowen, E. W., Pavletic, S. Z. & Pusic, I., 2025, (Accepted/In press) In: British Journal of Haematology.Research output: Contribution to journal › Letter › peer-review
-
Genomic alterations and transcriptional phenotypes in circulating free DNA and matched metastatic tumor
Takahashi, N., Pongor, L., Agrawal, S. P., Shtumpf, M., Gurjar, A., Rajapakse, V. N., Shafiei, A., Schultz, C. W., Kim, S., Roame, D., Carter, P., Vilimas, R., Nichols, S., Desai, P., Figg, W. D., Bagheri, M., Teif, V. B. & Thomas, A., Dec 2025, In: Genome Medicine. 17, 1, 15.Research output: Contribution to journal › Article › peer-review
Open Access -
Intermediate-dose posttransplantation cyclophosphamide for myeloablative HLA-haploidentical bone marrow transplantation
Hyder, M. A., Dimitrova, D., Sabina, R., DeVries, A., McCune, J. S., McAdams, M. J., Flomerfelt, F. A., McKeown, C., Sadler, J. L., Chai, A., Hughes, T. E., Napier, S., Stokes, A., Sponaugle, J., Rechache, K., Parta, M., Cuellar-Rodriguez, J., Figg, W. D., Choo-Wosoba, H., Steinberg, S. M., & 2 others, 27 May 2025, In: Blood Advances. 9, 10, p. 2553-2569 17 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab
Myojin, Y., Babaei, S., Trehan, R., Hoffman, C., Kedei, N., Ruf, B., Benmebarek, M. R., Bauer, K. C., Huang, P., Ma, C., Monge, C., Xie, C., Hrones, D., Duffy, A. G., Armstrong, P., Kocheise, L., Desmond, F., Buchalter, J., Galligan, M., Cantwell, C., & 18 others, 1 Jun 2025, In: Gut. 74, 6, p. 983-995 13 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Sustained Interferon Signature Suppression With Anifrolumab in a Patient With STING-Associated Vasculopathy with Onset in Infancy Refractory to JAK Inhibitor and Dazukibart Therapy
Alehashemi, S., Buehring, B., de Jesus, A. A., Gaurav, S., Rastegar, A., Baumgardner, A., Friend, K., Arisa, O. T., Figg, W. D., Fink, D., Kuhns, D. B., Colton, B., Peer, C. J. & Goldbach-Mansky, R., 2025, (Accepted/In press) In: Arthritis and Rheumatology.Research output: Contribution to journal › Article › peer-review
Open Access
Press/Media
-
-
Popular Cold Medicines Sold In New York State May Be Ineffective
28/10/23
1 item of Media coverage
Press/Media